PTX 2.56% 3.8¢ prescient therapeutics limited

Ann: Edison Investment Research Initiates Coverage, page-3

  1. 22,120 Posts.
    lightbulb Created with Sketch. 20
    From the Qtrly

    "The two clinical trials currently underway for PTX-200 in breast cancer and ovarian cancer remain funded by US government grants."

    The grants are from US Cancer Council and US Department of Defence which provides US validation for PTXs science which should make it easier for them to attract US Funding
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $30.60M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $47.91K 1.256M

Buyers (Bids)

No. Vol. Price($)
11 881755 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 150000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.